.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
This randomized trial evaluated whether a structured group cognitive-behavioral intervention could improve CPAP uptake and adherence in people newly diagnosed with obstructive sleep apnea. Participants received treatment as usual or treatment as usual plus two one-hour cognitive-behavioral sessions that incorporated education and experiences from actual CPAP users. At 28 days, the intervention group used CPAP for more hours and was more likely to initiate treatment. Measures of self-efficacy and social support also improved, suggesting that behavior and confidence can influence whether patients persist with therapy. The study is clinically useful because it demonstrates that CPAP adherence is not purely a device problem. Patient beliefs, expectations, support and early experience all matter. This aligns closely with the NAPCON sleep symposium's message that CPAP adherence begins with counseling. The findings also help explain why a single educational message may be insufficient for some patients. In practice, clinicians can consider structured, repeated support, early troubleshooting and reinforcement of self-efficacy, particularly in patients who are hesitant or struggling during the first weeks of treatment.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
This randomized trial evaluated whether a structured group cognitive-behavioral intervention could improve CPAP uptake and adherence in people newly diagnosed with obstructive sleep apnea. Participants received treatment as usual or treatment as usual plus two one-hour cognitive-behavioral sessions that incorporated education and experiences from actual CPAP users. At 28 days, the intervention group used CPAP for more hours and was more likely to initiate treatment. Measures of self-efficacy and social support also improved, suggesting that behavior and confidence can influence whether patients persist with therapy. The study is clinically useful because it demonstrates that CPAP adherence is not purely a device problem. Patient beliefs, expectations, support and early experience all matter. This aligns closely with the NAPCON sleep symposium's message that CPAP adherence begins with counseling. The findings also help explain why a single educational message may be insufficient for some patients. In practice, clinicians can consider structured, repeated support, early troubleshooting and reinforcement of self-efficacy, particularly in patients who are hesitant or struggling during the first weeks of treatment.
last month
Preclinical findings demonstrate that ginsenoside Ra1 preserves vascular integrity and attenuates multi-organ injury during sepsis by targeting non-muscle myosin heavy chain IIA (NMMHC IIA) and dampening TLR4/NF-κB/NLRP3 inflammatory signaling.
2 days back
An all-printed immunosensing microchip detects urinary sFlt-1 in just 10 minutes with 3.61 pg/mL sensitivity. By leveraging photonic bandgap engineering, this low-cost, cleanroom-free platform provides non-invasive preeclampsia screening, offering substantial benefits for point-of-care obstetric triage.
2 days back
Wearable ultrasound patches are transforming healthcare by shifting medicine from episodic evaluations to continuous monitoring. Discover how flexible acoustic transducers advance cardiovascular tracking, musculoskeletal imaging, neuromodulation, and on-demand closed-loop theranostics.
2 days back
A breakthrough study leverages natural language processing to accurately identify incident medication-related osteonecrosis of the jaw and track antiresorptive drug holidays from clinical narratives in electronic health records, advancing osteoporosis pharmacovigilance and dental safety.
Last week
Recent research defines ferro-aging as a conserved iron-lipid axis driving organ decline across primates. Age-related iron dyshomeostasis stimulates ACSL4-mediated lipid peroxidation, promoting cellular senescence. Notably, vitamin C directly inhibits ACSL4, suppressing phospholipid oxidation and multi-organ decay.
Last week
